Does RITUXIMAB Cause Product dose omission issue? 553 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 553 reports of Product dose omission issue have been filed in association with RITUXIMAB (Rituxan). This represents 0.3% of all adverse event reports for RITUXIMAB.
553
Reports of Product dose omission issue with RITUXIMAB
0.3%
of all RITUXIMAB reports
23
Deaths
185
Hospitalizations
How Dangerous Is Product dose omission issue From RITUXIMAB?
Of the 553 reports, 23 (4.2%) resulted in death, 185 (33.5%) required hospitalization, and 9 (1.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 553 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which RITUXIMAB Alternatives Have Lower Product dose omission issue Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE